(0.06%) 5 157.75 points
(0.07%) 38 861 points
(-0.03%) 17 995 points
(0.36%) $78.39
(0.47%) $2.15
(0.42%) $2 318.40
(1.63%) $27.13
(-0.40%) $961.45
(0.03%) $0.929
(-0.11%) $10.86
(0.01%) $0.797
(0.05%) $91.50
2.84% $ 1.450
@ $2.93
Emitido: 14 feb 2024 @ 15:42
Retorno: -50.43%
Señal anterior: feb 14 - 14:49
Señal anterior:
Retorno: -1.02 %
Live Chart Being Loaded With Signals
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients...
Stats | |
---|---|
Volumen de hoy | 4.87M |
Volumen promedio | 1.39M |
Capitalización de mercado | 119.15M |
EPS | $-0.690 ( 2024-03-20 ) |
Próxima fecha de ganancias | ( $-0.350 ) 2024-05-14 |
Last Dividend | $0.0100 ( 2018-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.440 |
ATR14 | $0.00600 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-25 | Orbimed Advisors Llc | Buy | 1 841 100 | Common Stock |
2024-01-25 | Orbimed Advisors Llc | Buy | 1 041 700 | Common Stock |
2024-01-25 | Orbimed Advisors Llc | Buy | 242 200 | Common Stock |
2024-01-25 | Gordon Carl L | Buy | 1 841 100 | Common Stock |
2024-01-25 | Gordon Carl L | Buy | 1 041 700 | Common Stock |
INSIDER POWER |
---|
58.38 |
Last 100 transactions |
Buy: 13 014 935 | Sell: 4 163 691 |
Volumen Correlación
Aceto Corporation Correlación
10 Correlaciones Más Positivas | |
---|---|
FGEN | 0.968 |
ALLR | 0.967 |
JBLU | 0.965 |
RIDE | 0.954 |
GSIT | 0.953 |
TSVT | 0.953 |
AIHS | 0.952 |
ELEV | 0.95 |
SEED | 0.95 |
PPBT | 0.95 |
10 Correlaciones Más Negativas | |
---|---|
HCKT | -0.963 |
XP | -0.961 |
NEOG | -0.96 |
VERA | -0.96 |
NCAC | -0.958 |
MSDA | -0.957 |
APEN | -0.957 |
BRIVU | -0.956 |
AGNCO | -0.955 |
MITA | -0.954 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aceto Corporation Correlación - Moneda/Commodity
Aceto Corporation Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-6.10M (0.00 %) |
EPS: | $-3.31 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-6.10M (0.00 %) |
EPS: | $-3.31 |
FY | 2022 |
Ingresos: | $24.99M |
Beneficio Bruto: | $19.98M (79.96 %) |
EPS: | $-1.630 |
FY | 2021 |
Ingresos: | $9.73M |
Beneficio Bruto: | $9.73M (100.00 %) |
EPS: | $-2.00 |
Financial Reports:
No articles found.
Aceto Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2009-06-11 |
Last Dividend | $0.0100 | 2018-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2018-10-09 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | $2.12 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.82 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0850 | 0.75% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.682 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.689 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 8.41 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.28 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 8.28 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.101 | -1.500 | 8.32 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6 335.00 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -2.18 | 2.00 | -0.726 | -1.452 | [0 - 30] |
freeCashFlowPerShareTTM | -2.28 | 2.00 | -1.141 | -2.28 | [0 - 20] |
debtEquityRatioTTM | 0.123 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -4.48 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.673 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.441 | 1.000 | -0.146 | 0 | [1 - 100] |
returnOnEquityTTM | -1.689 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -2.28 | 2.00 | -0.760 | -2.28 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -2.18 | 2.00 | -0.726 | -1.452 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0174 | 1.500 | -3.45 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -2.08 |
Aceto Corporation
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico